// App-Quantinova.ai

: IL-12 abrogates mechanisms of immune suppression by B-ALL

Researchers

Presenter

  • Rae Hunter

Principal Investigators

  • Curtis J. Henry

  • Christopher Porter

Medical Centers

  • Emory Univ. Sch. of Med

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Interleukin 12

Drug/Treatment

  • IL-12

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved